vs
Side-by-side financial comparison of Ameris Bancorp (ABCB) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Ameris Bancorp is the larger business by last-quarter revenue ($314.4M vs $270.4M, roughly 1.2× Enhabit, Inc.). Ameris Bancorp runs the higher net margin — 35.1% vs -14.3%, a 49.5% gap on every dollar of revenue. On growth, Ameris Bancorp posted the faster year-over-year revenue change (10.0% vs 4.7%). Over the past eight quarters, Ameris Bancorp's revenue compounded faster (2.3% CAGR vs 1.5%).
Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
ABCB vs EHAB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $314.4M | $270.4M |
| Net Profit | $110.5M | $-38.7M |
| Gross Margin | — | — |
| Operating Margin | — | -12.3% |
| Net Margin | 35.1% | -14.3% |
| Revenue YoY | 10.0% | 4.7% |
| Net Profit YoY | — | 15.9% |
| EPS (diluted) | $1.63 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $314.4M | — | ||
| Q4 25 | $307.1M | $270.4M | ||
| Q3 25 | $314.2M | $263.6M | ||
| Q2 25 | $300.7M | $266.1M | ||
| Q1 25 | $285.9M | $259.9M | ||
| Q4 24 | $290.8M | $258.2M | ||
| Q3 24 | $283.8M | $253.6M | ||
| Q2 24 | $300.6M | $260.6M |
| Q1 26 | $110.5M | — | ||
| Q4 25 | $108.4M | $-38.7M | ||
| Q3 25 | $106.0M | $11.1M | ||
| Q2 25 | $109.8M | $5.2M | ||
| Q1 25 | $87.9M | $17.8M | ||
| Q4 24 | $94.4M | $-46.0M | ||
| Q3 24 | $99.2M | $-110.2M | ||
| Q2 24 | $90.8M | $-200.0K |
| Q1 26 | — | — | ||
| Q4 25 | 45.9% | -12.3% | ||
| Q3 25 | 43.6% | 6.4% | ||
| Q2 25 | 47.4% | 6.3% | ||
| Q1 25 | 39.5% | 6.1% | ||
| Q4 24 | 43.3% | -16.0% | ||
| Q3 24 | 44.4% | -38.6% | ||
| Q2 24 | 42.1% | 4.3% |
| Q1 26 | 35.1% | — | ||
| Q4 25 | 44.2% | -14.3% | ||
| Q3 25 | 33.7% | 4.2% | ||
| Q2 25 | 36.5% | 2.0% | ||
| Q1 25 | 30.8% | 6.8% | ||
| Q4 24 | 42.5% | -17.8% | ||
| Q3 24 | 35.0% | -43.5% | ||
| Q2 24 | 30.2% | -0.1% |
| Q1 26 | $1.63 | — | ||
| Q4 25 | $1.59 | $-0.76 | ||
| Q3 25 | $1.54 | $0.22 | ||
| Q2 25 | $1.60 | $0.10 | ||
| Q1 25 | $1.27 | $0.35 | ||
| Q4 24 | $1.35 | $-0.92 | ||
| Q3 24 | $1.44 | $-2.20 | ||
| Q2 24 | $1.32 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $43.6M |
| Total DebtLower is stronger | — | $426.0M |
| Stockholders' EquityBook value | $4.1B | $534.0M |
| Total Assets | $28.1B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $43.6M | ||
| Q3 25 | — | $56.9M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | — | $39.5M | ||
| Q4 24 | — | $28.4M | ||
| Q3 24 | — | $45.7M | ||
| Q2 24 | — | $28.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | — | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M |
| Q1 26 | $4.1B | — | ||
| Q4 25 | $4.1B | $534.0M | ||
| Q3 25 | $4.0B | $566.8M | ||
| Q2 25 | $3.9B | $552.4M | ||
| Q1 25 | $3.8B | $543.2M | ||
| Q4 24 | $3.8B | $523.5M | ||
| Q3 24 | $3.7B | $566.1M | ||
| Q2 24 | $3.6B | $674.3M |
| Q1 26 | $28.1B | — | ||
| Q4 25 | $27.5B | $1.2B | ||
| Q3 25 | $27.1B | $1.2B | ||
| Q2 25 | $26.7B | $1.2B | ||
| Q1 25 | $26.5B | $1.2B | ||
| Q4 24 | $26.3B | $1.2B | ||
| Q3 24 | $26.4B | $1.3B | ||
| Q2 24 | $26.5B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $4.4M |
| Free Cash FlowOCF − Capex | — | $3.3M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $390.2M | $4.4M | ||
| Q3 25 | $104.9M | $37.8M | ||
| Q2 25 | $61.4M | $10.6M | ||
| Q1 25 | $116.9M | $17.9M | ||
| Q4 24 | $154.2M | $-4.1M | ||
| Q3 24 | $102.2M | $28.4M | ||
| Q2 24 | $-97.1M | $9.6M |
| Q1 26 | — | — | ||
| Q4 25 | $369.6M | $3.3M | ||
| Q3 25 | $100.5M | $36.2M | ||
| Q2 25 | $53.7M | $8.7M | ||
| Q1 25 | $114.2M | $17.6M | ||
| Q4 24 | $140.7M | $-4.7M | ||
| Q3 24 | $99.8M | $27.7M | ||
| Q2 24 | $-100.3M | $8.9M |
| Q1 26 | — | — | ||
| Q4 25 | 120.4% | 1.2% | ||
| Q3 25 | 32.0% | 13.7% | ||
| Q2 25 | 17.9% | 3.3% | ||
| Q1 25 | 39.9% | 6.8% | ||
| Q4 24 | 48.4% | -1.8% | ||
| Q3 24 | 35.2% | 10.9% | ||
| Q2 24 | -33.4% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | 0.4% | ||
| Q3 25 | 1.4% | 0.6% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 4.6% | 0.2% | ||
| Q3 24 | 0.8% | 0.3% | ||
| Q2 24 | 1.1% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.60× | — | ||
| Q3 25 | 0.99× | 3.41× | ||
| Q2 25 | 0.56× | 2.04× | ||
| Q1 25 | 1.33× | 1.01× | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | -1.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCB
Segment breakdown not available.
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
